Abstract
Cholelithiasis (gallstones) is a major medical and economic problem in the USA (Schoenfield, 1977; Schoenfield et al., 1981). It has been estimated to have a prevalence of 15 million women and five million men, and almost one million new cases are discovered each year (Ingelfinger, 1968; Friedman et al., 1966). Gallstones account for 5000–8000 deaths and a toll of $1 billion annually (Schoenfield et al, 1981).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abramowicz, M., ed.: Chenodiol for dissolving gallstones. Medical Letter 25:101,102,1983.
Admirand, W. H. and Small, D.M.: The physicochemical basis of cholesterol gallstone formation in man. J. Gin. Invest. 47:1043–1052, 1968.
Andrews, E., Schoenheimer, R., and Hrdina, L.: Etiology of gall stones. II. Role of the gallbladder. Proc. Soc. Exp. Biol. Med. 28:945,946,1931a.
Andrews, E., Schoenheimer, R., and Hrdina, L.: Etiology of gall stones. III. Bile salt-cholesterol ratio in human gall stone cases. Proc. Soc. Exp. Biol. Med. 28: 945–948, 1931b.
Andrews, E., Dostal, L. E., Goff, M., and Hrdina, L.: The mechanism of cholesterol gallstone formation. Ann. Surg. 96:615–623, 1932.
Bachrach, W. H. and Hof mann, A. F.: Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis Part I. Dig. Dis. Sci. 27:737–761, 1982.
Budavari, S., ed.: The Merck Index, 11th Ed., p. 1556, Merck & Co., Rahway, NJ, 1989.
Cole, W. H. and Harridge, W. H.: Disappearance of “stone” shadows in post-operative cholangiograms. JAMA 164: 238–243, 1957.
Danziger, R. G., Hofmann, A. F., Schoenfield, L. J., and Thistle, J. L.: Dissolution of cholesterol gallstones by chenodeoxycholic acid. N. Engl. J. Med. 286:1–8, 1972.
Fedorowski, T., Salen, G., Tint, G. S., and Mosbach, E.: Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterohgy 77:1068–1073, 1979.
Friedman, G. D., Kannel, W. B., and Dawber, T. R.: The epidemiology of gallbladder disease: Observations in the Framingham study. J. Chronic Dis. 19:273–292, 1966.
Hammarsten, O.: Zur Chemie der Galle. Ergeh. Physiol. 4:1–22, 1905.
Ingelfinger, F. J.: Digestive disease as a national problem. V. Gallstones. Gastroenterohgy 55:102–104, 1968.
Isaksson, B.: On the lipid constituents of normal bile. ActaSoc.Med.Upsala 56:177–195, 1951.
Isaksson, B.: On the lipid constituents of bile from human gallbladder containing cholesterol gallstones. A comparison with normal humanbladder bile. Ada Soc. Med. Upsala 59:277–295, 1954a.
Isaksson, B.: On the dissolving power of lecithin and bile salts for cholesterol in human bladder bile. Ada Soc. Med. Upsala 59:296–306, 1954b.
Johnston, C. G., Irvin, J. L., and Walton, C: The free choline and phospho-lipid of hepatic and gallbladder bile. J. Biol. Chem. 131:42S437,1939.
Linos, D. A., Beard, C. M., O’Fallon, W. M., Dockerty, M. B., Beart, R. W. Jr., and Kurland, L. T.: Cholecystectomy and carcinoma of the colon. Lancet 2:379–381, 1981.
Long, J. H. and Gephart, F.: On the behavior of lecithin with bile salts, and the occurrence of lecithin in bile. J. Am. Chem. Soc. 30:1312–1319, 1908.
Makino, I., Shinozaki, K., Yoshino, K., and Nakagawa, S.: Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn. J. Gastroenterol. 72: 690–702, 1975.
Maton, P. N., Murphy, G. M., and Dowling, R. H.: Ursodeoxycholic acid treatment of gallstones. Lancet 2:1297–1301, 1977.
Nakagawa, S., Makino, I., Ishizaki, T., and Dohi, I.: Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 2:367–369, 1977.
Nakayama, F.: Oralcholelitholysis—cheno versus urso. Japanese experience. Dig. Dis. Sci. 25:129–134, 1980.
Rains, A. J. H.: Gallstones, Causes and Treatment, Charles C. Thomas, Springfield, IL, 1964.
Rewbridge, A. G.: The disappearance of gallstone shadows following the prolonged administration of bile salts. Surgery 1:395–400, 1937.
Rosenak, B. D. and Kohlstaedt, K. G.: Bile salt therapy in liver and gall bladder disease. Am. J. Dig. Dis. Nutr. 3:577–580, 1936.
Salen, G., Tint, G. S., Eliav, B., Deering, N., and Mosbach, E. H.: Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid. J. Clin. Invest. 53:612–621, 1974.
Schoenfield, L. J.: Diseases of the Gallbladder and Biliary System, Wiley, New York, 1977.
Schoenfield, L. J., Lachin, J. M., The Steering Committee, and The National Cooperative Gallstone Study Group: Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The national cooperative gallstone study. Ann. Intern. Med. 95:257–282, 1981.
Schoenheimer, R. and Hrdina, L.: The etiology of gall stones. I. Chemical factors. Proc. Soc. Exp. Biol. Med. 28:944,945,1931.
Spanner, G. O. and Bauman, L.: The behavior of cholesterol and other bile constituents in solutions of bile salts. J. Biol. Chem. 98:181–183, 1932.
Stiehl, A., Czygan, P., Kommerell, B., Weis, H. J., and Holtermuller, K. H.: Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones. Gastroenterology 75:1016–1020, 1978.
Thistle, J. L. and Hofmann, A. F.: Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. N. Engl. J. Med. 289:655–659, 1973.
Thistle, J. L. and Schoenfield, L. J.: Induced alterations in composition of bile of persons having cholelithiasis. Gastroenterology 61:488–496, 1971.
Tint, G. S., Salen, G., and Shefer, S.: Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. Gastroenterology 91:1007–1018, 1986.
Tint, G. S., Salen, G., Colalillo, A., Graber, D., Verga, D., Speck, J., and Shefer, S.: Ursodeoxycholic acid: A safe and effective agent for dissolving cholesterol gallstones. Ann. Intern. Med. 97:351–356, 1982.
Tokyo Cooperative Gallstone Study Group: Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Gastroenterology 78:542–548, 1980.
Vernick, L. J. and Kuller, L. H.: Cholecystectomy and right-sided colon cancer: An epidemiological study. Lancet 2:381–383, 1981
Vlahcevic, Z. R., Bell, C. C., Buhac, I., Farrar, J. T., and Swell, L.: Diminished bile acid pool size in patients with gallstones. Gastroenterology 59: 165–173, 1970.
Ward, A., Brogden, R. N., Heel, R. C., Speight, T. M., and Avery, G. S.: Ursodeoxycholic acid. A review of its pharmacological properties and therapeutic efficacy. Drugs 27:95–131, 1984.
White, B. A., Fricke, R. J., and Hylemon, P. B.: 7β-Dehydroxylation of ursodeoxycholic acid by whole cells and cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 12708. J. Lipid Res. 23:145–153, 1982.
Wieland, H. and Reverey, G.: Untersuchungen über Gallensäuren. XXI. Mitteilung. Zur Kenntnis der menschlichen Galle, 1. Z. Physiol. Chem. 140:186–202, 1924.
Windhaus, A., Bohne, A., and Schwarzkopf, E.: Über die Cheno-desoxy-cholsäure. Z. Physiol. Chem. 140:177–185, 1924.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maxwell, R.A., Eckhardt, S.B. (1990). Chenodeoxycholic Acid and Ursodeoxycholic Acid. In: Drug Discovery. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0469-5_28
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0469-5_28
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6775-1
Online ISBN: 978-1-4612-0469-5
eBook Packages: Springer Book Archive